tuberculous pleurisy
Conditions
Interventions
Intervention Group: prednisolone
control:none
Sponsors
Daping Hospital, the Third Military Medical University, Chongqing, China
Eligibility
Sex/Gender
All
Age
12 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 12 to 70 years; 2. Genders Eligible for Study: Both; 3. Signed written informed consent; 4. Presented with clinical features suggesting pleural tuberculosis; 5. Had not previously received treatment or prophylaxis for tuberculosis; 6. Had not recently received treatment with glucocorticoids; 7. Were not pregnant or breast-feeding.
Exclusion criteria
Exclusion criteria: Failed to complete the screening procedures; Were seropositive for HIV; Tuberculous meningitis; Had risk factors for serious steroid-related adverse events (a history of diabetes, a history or clinical finding of hypertension, or a history of peptic ulcer disease or mental illness); Standard doses of antituberculosis drugs could not be used (as in participants with concurrent liver disease); Psychiatric illness; Alcoholism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of pleural thickening;Pulmonary function at completion of treatment;Adverse drug effect; | — |
Countries
China
Contacts
Public ContactCao Guoqiang
Daping Hospital, the Third Military Medical University, Chongqing, China
Outcome results
None listed